Position in FATE
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$1,316,865
+$927,120 QoQ
Shares Held
487,728
+50.2% QoQ
Ownership
0.407%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#27
of 156 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in FATE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026IEQ CAPITAL, LLC holds $235,945,693 across 100 Biotechnology names. FATE ranks #27 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
424,682 | $48,141,951 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
48,105 | $29,995,391 | |
| 3 | EXEL |
Exelixis, Inc.
|
451,768 | $24,580,696 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
37,339 | $18,547,400 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
197,988 | $11,328,873 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
58,834 | $11,018,430 | |
| 7 | CORT |
Corcept Therapeutics Inc
|
92,394 | $8,033,658 | |
| 8 | BHVN |
Biohaven Ltd.
|
475,865 | $7,080,871 |
All Filings in FATE
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,316,865 | 487,728 | Shares | Other | 2026-08-11 | |
| 2026-03-31 | $389,745 | 324,788 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $119,070 | 121,501 | Shares | Other | 2026-02-13 | |
| 2025-09-30 | $173,326 | 137,561 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $131,103 | 117,057 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $58,859 | 74,506 | Shares | Other | 2025-05-14 | |
| No filing history on record for this holder in this stock. | ||||||